Abdulfattah Al-Kadash

693 citations
6 papers · 433 indexed · 1 hit paper · h-index 5

Abdulfattah Al-Kadash

6 papers receiving 427 citations

Hit Papers

siRNA: Mechanism of action, challenges, and therapeutic a...296202120262022202450100150200250

Peers

Abdulfattah Al-Kadash
Comparison fields: 5 of 83
  • Cancer Research 101
  • Biomaterials 62
  • Molecular Biology 261
  • Pharmaceutical Science 22
  • Molecular Medicine 7
Replace Se‐Lim Kim with:
Se‐Lim Kim South Korea
Clement Penny South Africa
Liuyun Gong China
Martina Tilio Italy
Jiayi Qian China
Jingqing Le China
Mahsa Akbari Oryani Iran
Magdalena Rudzińska Poland
Ping Leng China
Abdulfattah Al-Kadash relative to Se‐Lim Kim South Korea Se‐Lim Kim's profile →
Citations per field
00.5×
Se‐Lim Kim · 1×
Citations per year

Countries citing papers authored by Abdulfattah Al-Kadash

Since Specialization
Citations

This map shows the geographic impact of Abdulfattah Al-Kadash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdulfattah Al-Kadash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdulfattah Al-Kadash more than expected).

Fields of papers citing papers by Abdulfattah Al-Kadash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdulfattah Al-Kadash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdulfattah Al-Kadash. The network helps show where Abdulfattah Al-Kadash may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Abdulfattah Al-Kadash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Abdulfattah Al-Kadash Line = papers co-authored together Abdulfattah Al-Kadash links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1 20242
2 202254
3 202238
4 202217
5
siRNA: Mechanism of action, challenges, and therapeutic approachesbreakdown →
2021296
6 202126

About Abdulfattah Al-Kadash

Abdulfattah Al-Kadash is a scholar working on Biomaterials, Pharmaceutical Science and Cancer Research, having authored 6 papers that have together received 433 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), RNA Interference and Gene Delivery (2 papers), MicroRNA in disease regulation (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Boron Compounds in Chemistry (1 paper), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper) and Nanoparticles: synthesis and applications (1 paper). The work is most often cited by research in Cancer Research (101 citations), Biomaterials (62 citations) and Molecular Biology (261 citations). Abdulfattah Al-Kadash has collaborated with scholars based in Jordan, Qatar and Australia. Frequent co-authors include Walhan Alshaer, Alaa A. A. Aljabali, Lobna Gharaibeh, Abdalla Awidi, Hadil Zureigat, Ma’mon M. Hatmal, Hamdi Nsairat, Ezaldeen Esawi, Hamid A. Bakshi and Khalid Al‐Batayneh. Their work appears in journals such as Molecules, European Journal of Pharmacology and RSC Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026